Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is haemodilution a good thing?

J A Dormandy, C J Yates, A Berent

    La Ricerca in Clinica E in Laboratorio
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Lowering high normal haematocrit may benefit cardiovascular disease patients. This approach, while not curing ischemia, can help compensate for narrowed blood vessels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of gestational diabetes mellitus, maternal obesity and associated perinatal outcomes over 10 years in an Australian tertiary maternity provider.

    Diabetes research and clinical practice·2023
    Same author

    Loss of bone density and bone strength following premenopausal risk-reducing bilateral salpingo-oophorectomy: a prospective controlled study (WHAM Study).

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
    Same author

    Peripheral quantitative computed tomography (pQCT)-based finite element analysis provides enhanced diagnostic performance in identifying non-vertebral fracture patients compared with dual-energy X-ray absorptiometry.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
    Same author

    A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control.

    Endocrine connections·2017
    Same author

    Thromboelastography.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.

    Diabetic medicine : a journal of the British Diabetic Association·2015
    Same journal

    Increase of plasma tissue-plasminogen activator antigen levels after induced abortion.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Role of prostaglandin E2 on defective interferon-gamma production during type B acute viral hepatitis.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The use of recombinant factor VIII in the management of hemophilia.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    The functioning liver mass.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. V. Activation-extinction line of cyclic hepatocyte activities.

    La Ricerca in clinica e in laboratorio·1991
    Same journal

    Liver system. IV. More on the liver micro-unit: physics and geometry of its action.

    La Ricerca in clinica e in laboratorio·1991
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Hematology

    Background:

    • High normal haematocrit is linked to increased cardiovascular disease risk.
    • Narrowed blood vessels (stenosis) impair blood flow, leading to ischemia.

    Purpose of the Study:

    • To review evidence on the clinical benefits of lowering haematocrit within the normal range.
    • To explore haemodilution as a compensatory mechanism for vascular narrowing.

    Main Methods:

    • Review of existing studies and clinical evidence.
    • Analysis of the effects of haematocrit reduction on cardiovascular risk and ischemia.

    Main Results:

    • Evidence suggests lowering haematocrit, even within the normal range, may offer clinical benefits.
    • Haemodilution can partially compensate for the effects of narrowed arteries.

    Related Experiment Videos

    Conclusions:

    • Reducing haematocrit in individuals with high normal levels may be a viable clinical strategy.
    • Haemodilution offers a compensatory approach for ischemic conditions due to vascular stenosis.